Stay updated with breaking news from Bidder Statement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TGM's Offer to Focus shareholders is 2 TGM shares for every 1 Focus share on issue as at 21 December 2021. Further details of the Offer and the implications for Focus shareholders (including the conditions to the Offer) are set out in the Bidder's Statement.
Wize Pharma and Cosmos Capital enter into Bid Implementation Agreement USA - English - Cosmos Capital, a digital infrastructure provider, to become publicly traded through a business combination with Wize - The combined company is expected to have approximately US$5 million in cash and cash equivalents at closing News provided by Share this article HOD HASHARON, Israel, and SYDNEY, Dec. 30, 2020 /PRNewswire/ -- Wize Pharma, Inc. (OTCQB: WIZP), a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, and Cosmos Capital Limited, a leading digital infrastruc...